HCG (Human Chorionic Gonadotropin)

What is HCG?

HCG (human chorionic gonadotropin) is the hormone that pregnancy tests detect — produced by the placenta to maintain the corpus luteum during early pregnancy. Its relevance to men's health comes from its structural similarity to LH (luteinizing hormone): HCG and LH share the same receptor on testicular Leydig cells, meaning HCG can substitute for LH to stimulate testosterone production directly in the testes.

On testosterone replacement therapy, LH falls to near zero — exogenous testosterone provides negative feedback to the hypothalamus and pituitary, shutting down natural LH production. Without LH, Leydig cells lose their primary stimulus, intratesticular testosterone drops dramatically, the testes atrophy, and spermatogenesis ceases. For men who want to maintain testicular function and fertility on TRT, something must substitute for LH. HCG was the standard solution for decades — administered alongside TRT, it directly stimulates Leydig cells, maintaining intratesticular testosterone and testicular size regardless of the LH suppression from exogenous testosterone.

The landscape has changed with gonadorelin's Category 1 return and widespread compounding availability. Gonadorelin stimulates the pituitary to release natural LH — a different, more physiological mechanism — and has become the preferred option for many TRT-prescribing physicians. However, HCG remains widely used and has specific advantages: it works directly at the testicular level (bypassing any pituitary insufficiency), has a longer half-life than gonadorelin (enabling twice-weekly vs. thrice-weekly dosing), and has decades more clinical experience behind it.

The HCG vs. gonadorelin question — which to use for testicular preservation on TRT — is one of the most active debates in men's health prescribing. Neither is universally superior; they address the same clinical goal through different mechanisms with different practical tradeoffs.

How it works

LH Receptor Agonism — Direct Testicular Stimulation

HCG binds the LH/HCG receptor (LHCGR) on testicular Leydig cells with very high affinity — higher affinity than LH itself. This receptor binding activates adenylyl cyclase → cAMP → PKA → steroidogenic enzyme activation (StAR, CYP11A1, HSD3B, CYP17A1) → testosterone synthesis. The result is direct, LH-independent testosterone production in the testes — a stimulus that works regardless of whether LH is present, which is why it works perfectly in the context of TRT-induced LH suppression.

Intratesticular Testosterone Maintenance

Intratesticular testosterone (ITT) concentrations are 50–100x higher than circulating testosterone — this concentration is required for spermatogenesis. When LH is suppressed by TRT, ITT drops dramatically even though circulating testosterone is elevated by the exogenous source. HCG restores ITT by providing LH receptor stimulation to Leydig cells, maintaining the intratesticular environment required for sperm production.

HCG vs. Gonadorelin — Mechanism Comparison

HCG directly stimulates LHCGR on Leydig cells → testicular testosterone, bypassing the pituitary entirely — it works even with pituitary insufficiency. Gonadorelin stimulates pituitary GnRH receptors → the pituitary releases natural LH → LH stimulates Leydig cells, requiring intact pituitary function. More physiological, but one step removed from the testes. Both produce comparable testicular preservation in most clinical settings — the choice comes down to practical factors (dosing frequency, cost, access, individual response) rather than categorical superiority of either approach.

Estrogen Considerations

HCG stimulates not just testosterone production but also aromatase activity in the testes — meaning HCG can significantly increase estradiol levels, sometimes more than equivalent testosterone doses. Men on HCG alongside TRT may need aromatase inhibitor management more carefully than those on TRT alone. Gonadorelin's LH-mediated mechanism produces less aromatase stimulation at equivalent testosterone effects.

What the research shows

What the community reports

HCG's men's health community has decades of accumulated experience — it was the standard for testicular preservation on TRT for 20+ years before gonadorelin. The community is large, experienced, and now engaged in the active HCG vs. gonadorelin debate.

Common misconceptions